-
Adherence
-
Children
-
Clinical reviews
-
Drug supply
-
Guidelines
-
Hepatitis and HIV coinfection
-
HIV Testing
-
Infant feeding
-
Laboratory monitoring
-
Malaria & HIV
-
Mental health and HIV
-
Neurological problems, including HIV dementia
-
Nutrition
-
Palliative care
-
Prevention
-
Prevention of mother-to child transmission
-
Scaling up treatment and models of service delivery
- Experts at 2009 HIV Implementers' meeting worry about sustainability of HIV programmes - 29/06/09
- Making the money work harder: the new reality of HIV scale-up - 29/06/09
- Dr Kevin De Cock calls for end to suboptimal HIV care for resource-limited settings - 29/06/09
- Using mobile phones in HIV care and prevention - 21/05/09
- Universal testing and immediate treatment could cut HIV infections by 95% in 10 years - 27/11/2008
- First-line antiretroviral therapy: not as simple as we'd like it to be - 19/06/08
- How to deliver good adherence support: lessons from round the world - 10/9/2007
- A follow-up on follow-up: shifting to a community-based response to improve retention in care - 31/8/2007
- Towards a comprehensive package of preventive and palliative care - 17/8/2007
- HIV treatment and displaced populations - 27/6/2007
- Brazil’s HIV/AIDS programme is a model for the rest of the world, but the cost of second-line therapies and the spread of HIV-1C could spell danger for the future - 27/10/2005
- Former manager of Botswana’s antiretroviral treatment programme describes barriers to rapid scale-up and suggest possible solutions at 2nd South African AIDS Conference - 27/10/2005
- Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part One - 27/10/2005
- Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part Two - 27/10/2005
- Getting antiretrovirals to where they are needed: drug procurement and quality - 27/10/2005
- Laboratory requirements for scaling up HIV treatment - 27/10/2005
- CDC pioneers family-based "preventive care" in Uganda as framework for rollout - 27/10/2005
- Integrating prevention research into the provision of HIV care - 23/5/2006
- Delivering 3 X 5: what are the next steps? - 27/10/2005
- Learning from Botswana - 27/10/2005
- MTCT-plus: Family-focused care and treatment - 27/10/2005
- Professional roles and ARV provision - 27/10/2005
- Amsterdam workshop on scaling up treatment (meeting report) - 27/10/2005
-
Side-effects
-
South Africa
-
Starting treatment
-
Stigma
-
Task shifting
-
Treatment failure
-
Tuberculosis
-
Viral load testing
feedback
Give us your views on our work
Scaling up treatment and models of service delivery
-
Experts at 2009 HIV Implementers' meeting worry about sustainability of HIV programmes - 29/06/09
-
Making the money work harder: the new reality of HIV scale-up - 29/06/09
-
Dr Kevin De Cock calls for end to suboptimal HIV care for resource-limited settings - 29/06/09
-
Using mobile phones in HIV care and prevention - 21/05/09
-
Universal testing and immediate treatment could cut HIV infections by 95% in 10 years - 27/11/2008
-
First-line antiretroviral therapy: not as simple as we'd like it to be - 19/06/08
-
How to deliver good adherence support: lessons from round the world - 10/9/2007
-
A follow-up on follow-up: shifting to a community-based response to improve retention in care - 31/8/2007
-
Towards a comprehensive package of preventive and palliative care - 17/8/2007
-
HIV treatment and displaced populations - 27/6/2007
-
Brazil’s HIV/AIDS programme is a model for the rest of the world, but the cost of second-line therapies and the spread of HIV-1C could spell danger for the future - 27/10/2005
-
Former manager of Botswana’s antiretroviral treatment programme describes barriers to rapid scale-up and suggest possible solutions at 2nd South African AIDS Conference - 27/10/2005
-
Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part One - 27/10/2005
-
Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part Two - 27/10/2005
-
Getting antiretrovirals to where they are needed: drug procurement and quality - 27/10/2005
-
Laboratory requirements for scaling up HIV treatment - 27/10/2005
-
CDC pioneers family-based "preventive care" in Uganda as framework for rollout - 27/10/2005
-
Integrating prevention research into the provision of HIV care - 23/5/2006
-
Delivering 3 X 5: what are the next steps? - 27/10/2005
-
Learning from Botswana - 27/10/2005
-
MTCT-plus: Family-focused care and treatment - 27/10/2005
-
Professional roles and ARV provision - 27/10/2005
-
Amsterdam workshop on scaling up treatment (meeting report) - 27/10/2005
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- Multiple treatment failures occur less frequently but remain associated with high mortality rates in North American cohort
- People with HIV providing high quality treatment support in community
- International donors must not retreat from commitment to HIV treatment scale-up, MSF warns
- Reassurance for HIV-positive women about short-term risk of bone loss
- Circumcision protects gay men who have a 'preference' for insertive sex from HIV
- Certain manifestations of stigma especially hurtful for people with HIV
- GSK and Pfizer launch joint HIV venture, ViiV Healthcare
- New hepatitis C protease inhibitors achieve 80% ‘cure’ rate in patients with genotype 1 infection
- President Obama announces US HIV travel ban will end in January 2010
- Darunavir/ritonavir, etravirine and raltegravir combination has 'remarkable' success in children with resistant virus